Czechia, June 4 -- Czechia based Takeda Pharmaceuticals Czech Republic s.r.o. has secured contract from Fakultni nemocnice Olomouc for Antivirals for systemic use - LP s obsahem maribaviru 2025. The value of the contract is worth 2751170508 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....